OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers - Vasan,S; Hurley,A; Schlesinger,SJ; Hannaman,D; Gardiner,DF; Dugin,DP; Boente-Carrera,MM; Vittorino,RM; Caskey,M; Andersen,J; Huang,Y; Cox,J; et al. (Retrovirology, 2009)